Alimera Sciences reported $21.52M in Cash and Equivalent for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Aerie Pharmaceuticals AERI:US $ 61.85M 18.11M
Alimera Sciences ALIM:US $ 21.52M 3.26M
Applied Genetic Technologies AGTC:US $ 90.52M 14.54M
Bayer BAYN:GR € 4316M 927M
Insmed INSM:US $ 846.56M 81.77M
Novartis NOVN:VX SF 7211M 2094M
Regeneron Pharmaceuticals REGN:US $ 3432.4M 1360.2M